Skip to main content
. Author manuscript; available in PMC: 2016 Jul 13.
Published in final edited form as: JAMA. 2008 May 14;299(18):2164–2171. doi: 10.1001/jama.299.18.2164

Table 1.

Baseline Participant Characteristicsa

Characteristics Clopidogrel
(n = 441)
Placebo
(n = 436)
Age, mean (SD), y 52.7 (14.7) 54.5 (14.4)

Male 273 (61.9) 275 (63.1)

Black 221 (50.1) 201 (46.1)

Body mass index, mean (SD)b 30.2 (8.6) 29.3 (7.5)

Blood pressure, mean (SD), mm Hg
  Systolic 141.0 (21.4) 139.9 (21.4)

  Diastolic 78.8 (13.4) 78.7 (14.3)

Diabetes mellitus 217 (49.2) 205 (47.0)

Cardiovascular diseasec 110 (24.9) 107 (24.5)

Cerebrovascular diseased 23 (5.2) 31 (7.1)

Peripheral arterial diseasee 16 (3.6) 12 (2.7)

Venous thromboembolic diseasef 12 (2.7) 15 (3.4)

Aspirin use 103 (23.4) 102 (23.4)

ACE inhibitor or ARB use 246 (55.8) 262 (60.1)

Statin use 164 (37.2) 171 (39.2)

Current tobacco use 91 (20.6) 81 (18.6)

Hemoglobin, mean (SD), g/dL 11.6 (1.8) 11.6 (1.7)

Serum albumin, mean (SD), g/dL 3.7 (0.6) 3.7 (0.6)

Preoperative vascular mapping 330 (75.9) 318 (73.8)

Previous arteriovenous access 79 (17.9) 81 (18.6)

Hemodialysis initiated before fistula creation 239 (54.2) 233 (53.4)

Study fistula
  Forearm 233 (52.8) 238 (54.6)

  Upper arm 208 (47.2) 198 (45.4)

  Radial artery–cephalic vein (forearm)g 209 (47.4) 209 (47.9)

  Brachial artery–cephalic vein (upper arm)h 142 (32.2) 138 (31.7)

  Brachial artery–basilic vein (upper arm)h 53 (12.0) 47 (10.8)

Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.

SI conversions: To convert hemoglobin to g/L, multiply by 10. To convert serum albumin to g/L, multiply by 10.

a

Data are expressed as No. (%) of participants unless otherwise noted. Comparisons were made using t tests for continuous variables and χ2 tests for categorical variables. For all comparisons, P > .05.

b

Body mass index was calculated as weight in kilograms divided by the height in meters squared.

c

Includes history of myocardial infarction, angina, coronary artery angioplasty, coronary artery bypass surgery, or congestive heart failure.

d

Includes history of stroke, transient ischemic attack, or carotid endarterectomy.

e

Includes history of nontraumatic amputation, lower extremity angioplasty or bypass surgery, or claudication.

f

Includes history of deep venous thrombosis or pulmonary embolism.

g

Other types of forearm anastomoses included ulnar artery–cephalic vein and radial artery–basilic vein.

h

Other types of upper arm anastomoses included proximal radial artery–cephalic vein and brachial artery–median cubital vein.